Geospatial distribution of Hepatitis E seroprevalence in Nepal, 2021
This study provides population-based serologic evidence that HEV is endemic in Nepal, with the greatest risk of infection in Kathmandu.
Authors
- Amy Dighe (ORCID: https://orcid.org/0000-0001-5024-8061)
- Deok Ryun Kim (ORCID: https://orcid.org/0009-0007-3085-6773)
- Jacqueline Kyungah Lim (ORCID: https://orcid.org/0000-0001-6744-7825)
- Andrew S. Azman (ORCID: https://orcid.org/0000-0001-8662-9077)
- Julia Lynch (ORCID: https://orcid.org/0000-0001-8048-5340)
- Nishan Katuwal (ORCID: https://orcid.org/0000-0002-8557-5879)
- Dipesh Tamrakar (ORCID: https://orcid.org/0000-0002-7258-1436)
- Chulwoo Rhee (ORCID: https://orcid.org/0000-0001-6868-7302)
- Nimesh Poudyal (ORCID: https://orcid.org/0000-0002-4156-7017)
- Haeun Cho
- R Amatya (ORCID: https://orcid.org/0000-0002-3587-4678)
- Il-Yeon Park
- Ramzi Mraidi
- Rajeev Shrestha
Institutions
- International Vaccine Institute (KR)
- Johns Hopkins University (US)
- Nepal Medical College Teaching Hospital (NP)
- Dhulikhel Hospital (NP)
- University Hospital of Geneva (CH)
- Kathmandu University (NP)
Publication Details
- Journal
- PLoS neglected tropical diseases
- Published
- 2024-12-23
- DOI
- https://doi.org/10.1371/journal.pntd.0012746
- Citations
- 1
- Primary Topic
- Hepatitis Viruses Studies and Epidemiology
- Type
- article
- Field-Weighted Citation Impact
- 0.37
Funders
- Bill and Melinda Gates Foundation